Imeik Technology Development Co.,Ltd. (SHE:300896)

China flag China · Delayed Price · Currency is CNY
115.78
+0.05 (0.04%)
Apr 16, 2026, 3:04 PM CST
Market Cap34.88B -42.1%
Revenue (ttm)2.45B -18.9%
Net Income1.29B -34.1%
EPS4.28 -34.2%
Shares Out301.43M
PE Ratio27.04
Forward PE24.80
Dividend1.60 (1.37%)
Ex-Dividend DateSep 26, 2025
Volume1,894,168
Average Volume2,385,551
Open113.50
Previous Close115.73
Day's Range113.50 - 116.19
52-Week Range112.30 - 202.88
Beta0.97
RSI37.27
Earnings DateMar 20, 2026

About SHE:300896

Imeik Technology Development Co.,Ltd. engages in the research and development, and transformation of biomedical materials and biopharmaceutical products in China. The company offers aesthetic medicine products, such as cross-linked sodium hyaluronate gel with PLLA-b-PEG microsphere; poly facial implant thread; medical sodium hyaluronate-hydroxypropyl methylcellulose gel; sodium hyaluronate composite solution for injection; modified sodium hyaluronate gel for injection; medical PVA gel ball-sodium hyaluronate-hydroxypropyl methylcellulose gel; a... [Read more]

Sector Healthcare
Founded 2004
Employees 1,458
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300896
Full Company Profile

Financial Performance

In 2025, SHE:300896's revenue was 2.45 billion, a decrease of -18.94% compared to the previous year's 3.03 billion. Earnings were 1.29 billion, a decrease of -34.05%.

Financial Statements